Strengthening Sales to Stabilize Orders in Existing Fields and Develop New Areas
First written in FY2016. 17 of 39 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-10-20.
The whole theme swung hardest in 2025: 1 of 6 companies on the "Worse" side.
7 other companies' latest entry also says "Advanced".
- 2026-10-20AdvancedOther Disclosures
「当社はチェーン事業・MIM 事業を一社で手掛ける業界唯一の企業です。多様化する市場ニーズに対応すべく、チェーン及び MIM の両面より、高付加価値製品を市場へ供給する PR や拡販を今後も実施してまいります。」
高機能金属展でMIM製品および主力チェーン製品を展示・PRし、チェーンとMIMの両面による高付加価値製品の拡販を今後も継続する方針を具体的な活動として示している。 - FY2026AdvancedAnnual report
「The temporary stagnation in orders caused by the 2024 Noto Peninsula Earthquake was resolved, and orders for automotive-related parts remained stable. We were also able to increase orders for medical parts, where market needs remain strong, through proactive proposal-based sales.」
Orders for automotive-related parts stabilized in the metal injection molding business, while orders related to medical parts also increased. Sales were ¥247 million and operating profit was ¥39 million, up 13.5% and 24.8%, respectively, from the previous fiscal year. - FY2026-H1AdvancedAnnual report
「In addition to increased orders related to medical parts, orders for automotive-related parts, which had stagnated due to the 2024 Noto Peninsula Earthquake, began to recover. As a result, sales were ¥113 million, up 28.7% year on year, and operating profit was ¥8 million, up 541.7%.」
In addition to increased orders related to medical parts, orders for automotive-related parts recovered, resulting in sales up 28.7% and operating profit up 541.7% in the metal injection molding business. - FY2025AdvancedAnnual report
「Orders related to automotive parts temporarily stagnated due to the 2024 Noto Peninsula Earthquake, but we were able to increase orders related to medical parts. As a result, sales were ¥217 million and operating profit was ¥31 million.」
Increased orders related to medical parts resulted in sales of ¥217 million and operating profit of ¥31 million in the metal injection molding business. This reflects progress in line with the existing policy of securing orders in existing fields and expanding in the medical equipment sector. - FY2025-H1Decline in orders due to the Noto Peninsula EarthquakeAnnual report
「We are conducting sales activities to expand orders, mainly in the medical equipment sector, but the recovery of customers affected by the Noto Peninsula Earthquake has been delayed, resulting in lower orders. As a result, sales were ¥87 million and operating profit was ¥1 million.」
While continuing efforts to expand orders, mainly in the medical equipment sector, delayed recovery by customers affected by the Noto Peninsula Earthquake resulted in lower orders in the metal injection molding business. - FY2024Full-year confirmation of lower sales and operating profit due to the loss of automotive spot ordersAnnual report
「We are conducting sales activities to expand orders, mainly in the medical equipment sector, but spot orders from the automotive industry ceased. As a result, sales were ¥207 million, down 17.4% from the previous fiscal year, and operating profit was ¥27 million, down 45.7%.」
While continuing efforts to expand orders in the medical equipment sector, the loss of spot orders from the automotive industry was confirmed for the full year, resulting in lower sales and operating profit in the metal injection molding business. - FY2024-Q3Widening decline in sales and operating profit due to the continued loss of spot orders from the automotive industryAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but spot orders from the automotive industry ceased. As a result, sales were ¥164 million, down 14.3% year on year, and operating profit was ¥25 million, down 29.4%.」
While continuing efforts to expand orders, mainly in the medical equipment sector, the loss of spot orders from the automotive industry continued, resulting in sales down 14.3% and operating profit down 29.4% in the metal injection molding business. - FY2024-Q2Lower sales and operating profit due to the continued loss of spot orders from the automotive industryAnnual report
「We are conducting sales activities to expand orders, mainly in the medical equipment sector, but spot orders from the automotive industry ceased. As a result, sales were ¥112 million, down 6.5% year on year, and operating profit was ¥21 million, down 20.0%.」
While continuing efforts to expand orders, mainly in the medical equipment sector, the loss of spot orders from the automotive industry resulted in lower sales and operating profit in the metal injection molding business. - FY2024-Q1Lower sales and operating profit due to the loss of spot orders from the automotive industryAnnual report
「We are conducting sales activities to expand orders, mainly in the medical equipment sector, but spot orders from the automotive industry ceased. As a result, sales were ¥52 million, down 1.8% year on year, and operating profit was ¥8 million, down 21.8%.」
While continuing sales activities, mainly in the medical equipment sector, the loss of spot orders from the automotive industry resulted in lower sales and operating profit in the metal injection molding business. - FY2023-Q3AdvancedAnnual report
「Orders in the medical equipment sector increased, while orders from the automotive industry also rose temporarily. As a result, sales were ¥191 million, up 24.3% year on year, and operating profit was ¥36 million, up 132.2%.」
In addition to higher orders in the medical equipment sector, temporary growth in orders from the automotive industry resulted in sales up 24.3% and operating profit up 132.2% in the metal injection molding business. - FY2023-Q2AdvancedAnnual report
「Orders in the medical equipment sector increased, while orders from the automotive industry also rose temporarily. As a result, sales were ¥120 million, up 30.9% year on year, and operating profit was ¥27 million, up 343.1%.」
In addition to higher orders, mainly in the medical equipment sector, temporary growth in orders from the automotive industry resulted in sales up 30.9% and operating profit up 343.1% in the metal injection molding business. - FY2023-Q1AdvancedAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, sales were ¥53 million, up 7.2% year on year, and operating profit was ¥10 million, up 66.6%.」
Continued sales efforts to expand orders, mainly in the medical equipment sector, resulted in sales up 7.2% and operating profit up 66.6% in the metal injection molding business. - FY2022AdvancedAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, sales were ¥208 million, up 18.6% year on year, and operating profit was ¥17 million, up 46.9%.」
Continued sales efforts, mainly in the medical equipment sector, resulted in sales up 18.6% and operating profit up 46.9% in the metal injection molding business. - FY2022-Q3AdvancedAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, sales were ¥154 million, up 22.4% year on year, and operating profit was ¥15 million, up 77.6%.」
Continued efforts to expand orders, mainly in the medical equipment sector, resulted in sales up 22.4% and operating profit up 77.6% in the metal injection molding business. - FY2022-Q2AdvancedAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, sales were ¥92 million, up 19.4% year on year, and operating profit was ¥6 million, up 55.8%.」
Continued sales efforts, mainly in the medical equipment sector, resulted in sales up 19.4% and operating profit up 55.8% in the metal injection molding business. - FY2022-Q1Higher sales and lower operating profit in the medical equipment sectorAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, sales were ¥49 million, up 11.5% year on year, and operating profit was ¥6 million, down 11.3%.」
Continued efforts to expand orders, mainly in the medical equipment sector, resulted in sales in the metal injection molding business up 11.5%, while operating profit declined 11.3%. - FY2021Full-year confirmation of the decline in mass-produced product salesAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but sales of mass-produced products declined. As a result, sales were ¥176 million, down 5.0% year on year, and operating profit was ¥12 million, down 57.4%.」
While continuing efforts to expand orders, mainly in the medical equipment sector, the decline in mass-produced product sales resulted in lower sales and operating profit for the full year in the metal injection molding business. The company also maintained its policy of increasing its market share in the high-performance medical equipment sector by using the hollow MIM process. - FY2021-Q3Continued decline in mass-produced product sales despite continued sales efforts in the medical equipment sectorAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but sales of mass-produced products declined. As a result, sales were ¥125 million, down 9.4% year on year, and operating profit was ¥8 million, down 50.3%.」
While continuing sales efforts, mainly in the medical equipment sector, the decline in mass-produced product sales resulted in sales down 9.4% and operating profit down 50.3% in the metal injection molding business. - FY2021-Q2Continued decline in mass-produced product sales despite continued sales efforts in the medical equipment sectorAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but sales of mass-produced products declined. As a result, sales were ¥77 million, down 18.4% year on year, and operating profit was ¥3 million, down 70.7%.」
While continuing sales efforts, mainly in the medical equipment sector, the decline in mass-produced product sales resulted in sales down 18.4% and operating profit down 70.7% in the metal injection molding business. - FY2021-Q1Decline in mass-produced product sales despite continued sales efforts in the medical equipment sectorAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but sales of mass-produced products declined. As a result, sales were ¥44 million, down 12.8% year on year, and operating profit was ¥7 million, down 4.6%.」
While continuing sales efforts, mainly in the medical equipment sector, sales of mass-produced products declined, resulting in lower sales and operating profit in the metal injection molding business. - FY2020Focus on the hollow MIM process and the medical equipment sectorAnnual report
「Among our metal injection molding technologies, we also work with the highly challenging hollow MIM process, which has been adopted by only a few domestic manufacturers. Going forward, we intend to increase our market share, particularly in the high-performance therapeutic equipment segment of the medical equipment industry.」
The company has set out a specific policy of using the hollow MIM process to increase its market share in the high-performance therapeutic equipment segment of the medical equipment industry. - FY2020-Q3Continued decline in mass-produced product sales, resulting in lower sales and operating profitAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but a customer reduced production for China, resulting in lower sales of mass-produced products. As a result, sales were ¥139 million, down 10.5% year on year, and operating profit was ¥17 million, down 50.1%.」
While continuing sales efforts, mainly in the medical equipment sector, sales of mass-produced products declined due to lower production for China by a customer, resulting in sales down 10.5% and operating profit down 50.1% in the metal injection molding business. - FY2020-Q2Continued decline in mass-produced product sales due to lower production for ChinaAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but a customer reduced production for China, resulting in lower sales of mass-produced products. As a result, sales were ¥94 million, down 9.2% year on year, and operating profit was ¥13 million, down 43.4%.」
While continuing sales efforts, mainly in the medical equipment sector, sales of mass-produced products declined due to lower production for China by a customer, resulting in lower sales and operating profit in the metal injection molding business. - FY2020-Q1Decline in mass-produced product sales due to lower production for ChinaAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector, but a customer reduced production for China, resulting in lower sales of mass-produced products. As a result, sales were ¥51 million, down 2.4% year on year, and operating profit was ¥7 million, down 47.8%.」
While continuing sales efforts, mainly in the medical equipment sector, sales of mass-produced products declined due to lower production for China by a customer, resulting in lower sales and operating profit in the metal injection molding business. - FY2019AdvancedAnnual report
「In the metal injection molding business, we continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, some products moved into mass production, increasing revenue. Sales were ¥194 million, up 8.2% year on year, and operating profit was ¥38 million, up 100.8%.」
Some products moved into mass production as a result of continued sales efforts, mainly in the medical equipment sector, with sales up 8.2% and operating profit up 100.8%. - FY2019-Q3AdvancedAnnual report
「We continued sales efforts to expand orders, mainly in the medical equipment sector. As a result, sales were ¥155 million, up 25.4% year on year, and operating profit was ¥35 million, up 245.0%.」
Continued efforts to expand orders, mainly in the medical equipment sector, resulted in sales up 25.4% and operating profit up 245.0% in the metal injection molding business. - FY2019-Q2AdvancedAnnual report
「We continued sales activities aimed at expanding orders, mainly in the medical-equipment field. As a result, net sales were ¥104 million, up 37.4% year on year, and operating profit was ¥23 million, up 408.0%.」
Sales activities aimed at expanding orders, mainly in the medical-equipment field, continued, and Metal Injection Molding Business net sales increased 37.4% and operating profit increased 408.0%. - FY2019-Q1AdvancedAnnual report
「We continued sales activities aimed at expanding orders, mainly in the medical-equipment field. As a result, net sales were ¥52 million, up 33.2% year on year, and operating profit was ¥14 million, up 255.1%.」
Sales activities aimed at expanding orders, mainly in the medical-equipment field, continued, and Metal Injection Molding Business net sales increased 33.2% and operating profit increased 255.1%. - FY2018Full-year confirmation of the decline in automotive-parts salesAnnual report
「In the Metal Injection Molding Business, we worked to expand orders, mainly in the medical-equipment field, but sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥179 million, down 28.7% year on year, and operating profit was ¥18 million, down 46.0%.」
While efforts to expand orders in the medical-equipment field continued, the decline in automotive-parts sales due to model changes was also confirmed for the full year. - FY2018-Q3Continued decline in automotive-parts salesAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥123 million, down 41.7% year on year, and operating profit was ¥10 million, down 72.9%.」
While efforts to expand orders, mainly in the medical-equipment field, continued, the decline in automotive-parts sales due to model changes persisted, resulting in significant declines in Metal Injection Molding Business net sales and operating profit. - FY2018-Q2Automotive-parts sales declined despite continued efforts to expand orders in the medical-equipment fieldAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥75 million, down 43.2% year on year, and operating profit was ¥4 million, down 81.1%.」
While efforts to expand orders in the medical-equipment field continued, the decline in automotive-parts sales due to model changes persisted, resulting in significant declines in Metal Injection Molding Business net sales and operating profit. - FY2018-Q1Automotive-parts sales declined despite continued efforts to expand orders in the medical-equipment fieldAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥39 million, down 40.3% year on year, and operating profit was ¥4 million, down 66.3%.」
While efforts to expand orders in the medical-equipment field continued, automotive-parts sales declined significantly due to model changes, resulting in lower net sales and operating profit in the Metal Injection Molding Business. - FY2017Lower sales and operating profit amid efforts to expand ordersAnnual report
「Although we worked to expand orders, mainly in the medical-equipment field, sales of automotive parts declined significantly due to model changes. As a result, net sales were ¥252 million, down 8.9% year on year, and operating profit was ¥35 million, down 32.6%.」
While efforts to expand orders, mainly in the medical-equipment field, continued, the decline in automotive-parts sales due to model changes caused both net sales and operating profit in the Metal Injection Molding Business to decrease. - FY2017-Q3Slightly higher sales and lower operating profit amid efforts to expand ordersAnnual report
「We worked to expand orders, mainly in the medical-equipment field. As a result, net sales were ¥212 million, up 0.3% year on year, while operating profit was ¥37 million, down 8.3%.」
Efforts to expand orders, mainly in the medical-equipment field, continued. Metal Injection Molding Business net sales increased 0.3% year on year, while operating profit declined 8.3%. - FY2017-Q2Lower sales and higher operating profit amid efforts to expand ordersAnnual report
「We worked to expand orders, mainly in the medical-equipment field. As a result, net sales declined to ¥133 million, down 3.0% year on year, while operating profit increased to ¥24 million, up 5.1%.」
Efforts to expand orders, mainly in the medical-equipment field, continued, while Metal Injection Molding Business net sales declined 3.0% and operating profit increased 5.1%. - FY2017-Q1AdvancedAnnual report
「We worked to expand orders, mainly in the medical-equipment field. As a result, net sales were ¥66 million, up 3.2% year on year, and operating profit was ¥12 million, up 66.0%.」
Regarding efforts to expand orders, mainly in the medical-equipment field, the company reports quarterly net sales growth of 3.2% and operating profit growth of 66.0% in the Metal Injection Molding Business. - FY2016First statedAnnual report
「In the Metal Injection Molding Business, we will pursue more proactive sales activities to secure stable order volumes from the existing automotive, medical-equipment, and precision-equipment fields and to develop new fields.」
The company outlines a policy of developing new fields through sales activities while stabilizing orders in the existing automotive, medical-equipment, and precision-equipment fields.